Nucleus N22 Cochlear Implant Systems
FDA premarket approval P890027/S059 · decided 2017-11-17
Approval details
- PMA number
- P890027
- Supplement
- S059
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- Nucleus N22 Cochlear Implant Systems
- Generic name
- Implant, cochlear
- Applicant
- Cochlear Americas
- Date received
- 2017-05-23
- Decision date
- 2017-11-17
- Days to decision
- 178 days
- Decision code
- APPR
- Product code
- MCM
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Lone Tree, CO
- Statement
- Approval order for the remote programing of Nucleus N22 Cochlear Implant System using telehealth technology should be issued.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.